Aspiriant LLC’s Enterprise Products Partners EPD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-186,000
Closed -$2.94M 209
2020
Q3
$2.94M Buy
+186,000
New +$3.26M 0.23% 52
2019
Q2
Sell
-13,365
Closed -$388K 233
2019
Q1
$388K Buy
+13,365
New +$373K 0.03% 161
2018
Q3
Sell
-10,660
Closed -$295K 246
2018
Q2
$295K Buy
+10,660
New +$292K 0.03% 202
2017
Q2
Sell
-9,065
Closed -$250K 215
2017
Q1
$250K Buy
+9,065
New +$253K 0.02% 186

Other funds holding EPD

Aspiriant LLC's EPD Position: Q4 2020 in Review

Aspiriant LLC sold out of Enterprise Products Partners (EPD) in Q4 2020, closing a stake of 186,000 shares — an estimated $2.94M sold.

Aspiriant LLC first reported a position in EPD in Q1 2017 and held it in 4 quarters. The position peaked at $2.94M in Q3 2020. 1,005 funds tracked by Wall St. Rank hold EPD as of Q4 2020.

  • Aspiriant LLC reported no remaining Enterprise Products Partners position as of Q4 2020 after selling out during the quarter.
  • Aspiriant LLC sold 186,000 Enterprise Products Partners shares in Q4 2020, an estimated $2.94M.
  • Aspiriant LLC first reported a position in Enterprise Products Partners in Q1 2017 and held it in 4 quarters.
  • Aspiriant LLC's Enterprise Products Partners position peaked at $2.94M in Q3 2020.
  • 1,005 funds tracked by Wall St. Rank held Enterprise Products Partners as of Q4 2020.

Based on Aspiriant LLC's 13F filing for Q4 2020, filed 1 Feb 2021.